Detalles de la búsqueda
1.
Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study.
Ann Rheum Dis
; 78(6): 754-760, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30902820
2.
Prognostic and predictive value of p-Akt, EGFR, and p-mTOR in early breast cancer.
Strahlenther Onkol
; 190(7): 636-8, 640-5, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24658605
3.
Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial.
BMC Cancer
; 14: 515, 2014 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25026897
4.
alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies.
BMC Clin Pathol
; 14: 28, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24987308
5.
Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial.
Breast Cancer Res Treat
; 132(2): 609-19, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22187126
6.
Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab.
J Transl Med
; 10: 212, 2012 Oct 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-23092535
7.
HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy.
J Transl Med
; 10: 10, 2012 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-22240029
8.
Volumetric and MGMT parameters in glioblastoma patients: survival analysis.
BMC Cancer
; 12: 3, 2012 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-22214427
9.
Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS).
BMC Cancer
; 12: 342, 2012 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-22866924
10.
XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis.
BMC Cancer
; 12: 271, 2012 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-22748098
11.
Prognostic utility of ß-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study.
Breast Cancer Res Treat
; 127(1): 179-93, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21390496
12.
Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 655064, an Antagonistic Anti-CD40 Antibody, in Healthy Subjects: A Potential Novel Treatment for Autoimmune Diseases.
J Clin Pharmacol
; 58(12): 1566-1577, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30113724
13.
p85 protein expression is associated with poor survival in HER2-positive patients with advanced breast cancer treated with trastuzumab.
Pathol Oncol Res
; 21(2): 273-82, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25098276
14.
Prognostic markers in early-stage colorectal cancer: significance of TYMS mRNA expression.
Anticancer Res
; 34(9): 4949-62, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25202077
15.
The androgen receptor as a surrogate marker for molecular apocrine breast cancer subtyping.
Breast
; 23(3): 234-43, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24703723
16.
Evaluation of current prognostic and predictive markers in breast cancer: a validation study of tissue microarrays.
Anticancer Res
; 33(5): 2139-45, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23645767
17.
Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer.
PLoS One
; 8(8): e70429, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23950933
18.
Prognostic significance of ESR1 gene amplification, mRNA/protein expression and functional profiles in high-risk early breast cancer: a translational study of the Hellenic Cooperative Oncology Group (HeCOG).
PLoS One
; 8(7): e70634, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23923010
19.
Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.
Clin Breast Cancer
; 12(3): 183-93, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22607768
Resultados
1 -
19
de 19
1
Próxima >
>>